Tag |
Content |
dbPAF ID |
dbPAF-0051002 |
Uniprot Accession |
E9Q9A9; OAS2_MOUSE; Q8K4E5; Q8VI92; |
Genbank Protein ID |
NP_660262.2; XP_006530388.1; |
Genbank Nucleotide ID |
NM_145227.3; XM_006530325.2; |
Protein Name |
2'-5'-oligoadenylate synthase 2 |
Protein Synonyms/Alias |
|
Gene Name |
Oas2 |
Gene Synonyms/Alias |
oasl11; |
Organism |
Mus musculus(Mouse) |
NCBI Taxa ID |
10090 |
Functional Description (View all) |
Interferon-induced, dsRNA-activated antiviral enzyme which plays a critical role in cellular innate antiviral response. In addition, it may also play a role in other cellular processes such as apoptosis, cell growth, differentiation and gene regulation. Synthesizes higher oligomers of 2'-5'-oligoadenylates (2-5A) from ATP which then bind to the inactive monomeric form of ribonuclease L (RNase L) leading to its dimerization and subsequent activation. Activation of RNase L leads to degradation of cellular as well as viral RNA, resulting in the inhibition of protein synthesis, thus terminating viral replication. Can mediate the antiviral effect via the classical RNase L-dependent pathway or an alternative antiviral pathway independent of RNase L.Functional Description
Interferon-induced, dsRNA-activated antiviral enzyme which plays a critical role in cellular innate antiviral response. In addition, it may also play a role in other cellular processes such as apoptosis, cell growth, differentiation and gene regulation. Synthesizes higher oligomers of 2'-5'-oligoadenylates (2-5A) from ATP which then bind to the inactive monomeric form of ribonuclease L (RNase L) leading to its dimerization and subsequent activation. Activation of RNase L leads to degradation of cellular as well as viral RNA, resulting in the inhibition of protein synthesis, thus terminating viral replication. Can mediate the antiviral effect via the classical RNase L-dependent pathway or an alternative antiviral pathway independent of RNase L.
|
Phosphorylation Sites
|
dbPAF PTMs: 2 Position | Peptides | Source | References ( PMIDs ) |
---|
600 | RKMKPKASLPPKYAL | PhosphoSitePlus | 22135298 | 640 | VLDLVIKYRQLCIFW | PhosphoSitePlus | 22135298 |
|
Sequence (Fasta) | MGNWLTGNWS SDRSSGYSSG WSPGGSSGVP SGPVHKLEKS IQANLTPNEN CLKQIAVSSV 60 PSQKLEGYIQ ENLKPNRESL KQIDQAVDAI WDLLRSQIPV KEVAKGGSYG RETALRGCSD 120 GTLVLFMDCF QQFQDQIKYQ DAYLDVIELW LKIHEKKSVK HEHALVVQVS VPGQRILLQL 180 LPVFNPLRSN ENPSSCVYVD LKKSMDQVRA SPGEFSDCFT TLQQRFFKKY PQRLKDLILL 240 VKHWYEQCQE KWKTPPPQPL LYALELLTVY AWEQGCQAED FDMAQGVRTV LRLIQRPTEL 300 CVYWTVNYNF EDETVRNILL HQLRSQRPVI LDPTDPTNNV GKDDGFWELL TEEAMAWLYS 360 PSLNTESPAP YWDVLPMPLF VTPSHLLNKF IKDFLQPNKL FLKQIKEAVD IICSFLKNVC 420 FLNSDTKVLK TVKGGSTAKG TALKRGSDAD IVVFLSSLES YDSLKTNRSQ FVQEIQKQLE 480 EFVQAQEWEV TFEISKWKAP RVLSFTLKSK TLNESVEFDV LPAYDALGQL RSDFTLRPEA 540 YKDLIELCAS QDIKEGEFSI CFTELQRNFI QTRPTKLKSL LRLIKHWYKQ YERKMKPKAS 600 LPPKYALELL TVYAWEQGSG TDDFDIAEGF RTVLDLVIKY RQLCIFWTVN YNFEEEYMRK 660 FLLTQIQKKR PVILDPADPT GDVGGGDRWC WHLLAEEAKE WLSSPCFQVE QKGLVQPWKV 720 PVMQTPGSCG GQIYPTVGGV TK
743Fasta Sequence
>E9Q9A9|Oas2|Mus musculus(Mouse) MGNWLTGNWSSDRSSGYSSGWSPGGSSGVPSGPVHKLEKSIQANLTPNENCLKQIAVSSVPSQKLEGYIQENLKPNRESLKQIDQAVDAIWDLLRSQIPVKEVAKGGSYGRETALRGCSDGTLVLFMDCFQQFQDQIKYQDAYLDVIELWLKIHEKKSVKHEHALVVQVSVPGQRILLQLLPVFNPLRSNENPSSCVYVDLKKSMDQVRASPGEFSDCFTTLQQRFFKKYPQRLKDLILLVKHWYEQCQEKWKTPPPQPLLYALELLTVYAWEQGCQAEDFDMAQGVRTVLRLIQRPTELCVYWTVNYNFEDETVRNILLHQLRSQRPVILDPTDPTNNVGKDDGFWELLTEEAMAWLYSPSLNTESPAPYWDVLPMPLFVTPSHLLNKFIKDFLQPNKLFLKQIKEAVDIICSFLKNVCFLNSDTKVLKTVKGGSTAKGTALKRGSDADIVVFLSSLESYDSLKTNRSQFVQEIQKQLEEFVQAQEWEVTFEISKWKAPRVLSFTLKSKTLNESVEFDVLPAYDALGQLRSDFTLRPEAYKDLIELCASQDIKEGEFSICFTELQRNFIQTRPTKLKSLLRLIKHWYKQYERKMKPKASLPPKYALELLTVYAWEQGSGTDDFDIAEGFRTVLDLVIKYRQLCIFWTVNYNFEEEYMRKFLLTQIQKKRPVILDPADPTGDVGGGDRWCWHLLAEEAKEWLSSPCFQVEQKGLVQPWKVPVMQTPGSCGGQIYPTVGGVTK
|
Keyword |
KW-0007--Acetylation KW-0025--Alternative splicing KW-0051--Antiviral defense KW-0067--ATP-binding KW-0181--Complete proteome KW-0963--Cytoplasm KW-0256--Endoplasmic reticulum KW-0325--Glycoprotein KW-0391--Immunity KW-0399--Innate immunity KW-0449--Lipoprotein KW-0460--Magnesium KW-0479--Metal-binding KW-0492--Microsome KW-0496--Mitochondrion KW-0519--Myristate KW-0547--Nucleotide-binding KW-0548--Nucleotidyltransferase KW-0539--Nucleus KW-1185--Reference proteome KW-0677--Repeat KW-0694--RNA-binding KW-0808--Transferase
|
Interpro |
IPR006117--2-5-oligoadenylate_synth_CS IPR006116--2-5-oligoadenylate_synth_N IPR018952--2-5-oligoAdlate_synth_1_dom2/C IPR026774--2-5A_synthase IPR002934--Polymerase_NTP_transf_dom
|
PROSITE |
PS00832--25A_SYNTH_1 PS00833--25A_SYNTH_2 PS50152--25A_SYNTH_3
|
Pfam |
PF01909--NTP_transf_2 PF10421--OAS1_C
|
Gene Ontology |
GO:0005737--C:cytoplasm GO:0005783--C:endoplasmic reticulum GO:0016020--C:membrane GO:0005739--C:mitochondrion GO:0005634--C:nucleus GO:0048471--C:perinuclear region of cytoplasm GO:0001730--F:2'-5'-oligoadenylate synthetase activity GO:0005524--F:ATP binding GO:0003725--F:double-stranded RNA binding GO:0008270--F:zinc ion binding GO:0051607--P:defense response to virus GO:0045087--P:innate immune response GO:0006486--P:protein glycosylation GO:0018377--P:protein myristoylation GO:0006164--P:purine nucleotide biosynthetic process GO:0009615--P:response to virus GO:0006401--P:RNA catabolic process
|